Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-05-13 | Dr. van Es-Johansson has an M.D. and has served in executive roles in pharmaceutical companies. |
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-15 | Dr. van Es-Johansson received a M.D. from Erasmus University, Rotterdam, The Netherlands. We believe Dr. van Es-Johansson’s medical knowledge and experience in the pharmaceutical industry qualifies her to serve on the Board of Directors. |
| 2021-04-27 | Dr. van Es-Johansson received a M.D. from Erasmus University, Rotterdam, The Netherlands. We believe Dr. van Es-Johansson’s medical knowledge and experience in the pharmaceutical industry qualifies her to serve on the Board of Directors. |
| 2022-04-19 | Dr. van Es-Johansson received a M.D. from Erasmus University, Rotterdam, The Netherlands. We believe Dr. van Es-Johansson’s medical knowledge and experience in the pharmaceutical industry qualifies her to serve on the Board of Directors. |
| 2023-04-28 | Dr. van Es-Johansson received a M.D. from Erasmus University, Rotterdam, The Netherlands. We believe Dr. van Es-Johansson’s medical knowledge and experience in the pharmaceutical industry qualifies her to serve on the Board of Directors. |
| 2024-04-26 | Dr. van Es-Johansson received a M.D. from Erasmus University, Rotterdam, The Netherlands. |
Data sourced from SEC filings. Last updated: 2026-02-03